Abstract
No class of chemical compounds has contributed more toward the elimination of hospital trauma than anesthetics. These drugs have changed the operating room from a chamber of horrors to a place where medical care is provided in a tranquil atmosphere to some 50 million patients every year. When inhaled, anesthetics enter the brain and induce profound sleep (hypnosis), sedation (a passive state), muscle relaxation (flaccidity) and analgesia (the absence of pain) to the level required to perform surgery. Inhalation anesthetics leave the brain and the body chemically unchanged because they are exhaled and need not be metabolized to be eliminated. In addition, the newer inhalants are not metabolized to any great extent.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
N. A. Bergman, J. Am. Med. Assoc. 253, 675 (1935).
F. Boland, The First Anesthetic, p. 3ff, University of Georgia Press, Athens (1950).
C. W. Long, Southern Medical and Surgical Journal (New Series), 5 (1849).
C. Carlsson and S. Cooper, Anesth. Analg. 70, 339 (1990).
A. Dobkin, Development of New Volatile Inhalation Anesthetics, Vol. 6, p. 6, Excerpta Medica, New York, (1979).
W. G. M. Jones, in: Preparation, Properties and Industrial Applications of Organofluorine Compounds (R. E. Banks, ed.), pp. 157–192, Ellis Horwood, Chichester (1982)
E. R. Larsen, Fluorine Chem. Rev. 3, 3 (1969).
B. H. Robbins, J. Pharmacol. Exp. Ther. 86, 197 (1946).
J. G. Shukys, U.S. Patent 2, 830, 007 (to Air Reduction) [CA 52, 14561 (1958)].
J. C. Krantz, Profiles of Medical Science and Inspired Moments, 87, Lucas, Baltimore (1967).
R. C. Terrell, Br. J. Anaesth. 56 (Supplement), 3 (1984).
D. Halpern, Chemtech 19, 304 (1989).
A. K. Barbour, in: Organofluorine Chemicals and Their Industrial Applications (R. E. Banks ed.), p. 49, Ellis Horwood, Chichester (1979).
C. W. Suckling and J. Raventos, British Patent 767, 779, U.S. Patent 2, 921, 098 (to ICI) [CA 51, 15547 (1957)].
O. Scherer and H. Kuhn, German Patent 1, 161, 249 (to Hoechst) [CA 60, 9147 (1964)].
T. B. Gowland, British Patent 523, 499 (to ICI) [CA 35, 6265 (1941)].
E. R. Larsen, U.S. Patent 3, 264, 356 (to Dow) [CA 65, 16865 (1966)].
R. C. Terrell, U.S. Patent 3, 469, 011 (to Airco) [CA 72, 3025 (1970)].
W. Wang, S. Chen, W. Chang, and Z. Sun, Yaowu Fenxi Zazhi 5, 322 (1985) [CA 104, 95600 (1986)].
R. C. Terrell and K. Hansen, U.S. Patent 4, 365, 097 (to BOC) [CA 99, 5203 (1983)].
R. C. Terrell and K. Hansen, U.S. Patent 4, 346, 246 (to BOC) [CA 94, 83604 (1981)].
L. S. Croix, U.S. Patent 3, 637, 477 (to Airco). Note: This patent was not abstracted by Chemical Abstracts and is incorrectly listed in the patent concordance.
E. I. Eger II, A. E. White, C. L. Brown, C. G. Biava, T. H. Corbett, and W. C. Stevens, Anesth. Analg. 57, 678 (1978).
Anaquest, Internal Data.
J. Tarpley and P. Lawler, Anesthesia 44, 596 (1989).
D. Noble and L. Martin, Anesthesia 45, 339 (1990).
E. I. Eger II, Anesth. Analg. 66, 971 (1987).
R. Wallin, B. Regan, M. Napoli, and J. Stern, Anesth. Analg. 54, 758 (1975).
Personal communication from Maruishi.
C. Coon and R. Simon, U.S. Patent 4, 250, 334 (to Baxter) [CA 94, 208538 (1981)].
B. Regan and J. Longstreet, U.S. Patent 3, 683, 092 (to Baxter) [CA 77, 156346 (1972)].
D. Halpern and M. L. Robin, U.S. Patent 4, 874, 901 (to BOC) [CA 112, 157680 (1990)].
C. Huang and G. G. Vernice, U.S. Patent 4, 874, 902 (to BOC) [CA 112, 157679 (1990)].
T. Patrick, K. John, D. White, W. Bertrand, R. Mokhtar, M. Kilbourn, and M. Welch, Can. J. Chem. 64, 138 (1986).
D. Halpern and M. L. Robin, U.S. Patent 4, 996, 371 (to BOC) [CA 115, 28690 (1991)].
C. Hanaki, K. Fujii, M. Mono, and T. Tashima, Hiroshima J. Med. Sci. 36, 61 (1987) [CA 107, 242577 (1987)].
D. Strum, B. Johnson, and E. Eger II, Anesthesiology 67, 779 (1987).
C. Huang, V. S. Venturella, A. L. Cholli, F. M. Venutolo, A. T. Silbermann, and G. G. Vernice, J. Fluorine Chem. 45, 239 (1989).
P. F. Leonard, Anesth. Analg. 54, 238 (1975).
E. I. Eger II, Anesth. Analg. 66, 983 (1987).
E. I. Eger II and B. Johnson, Anesth. Analg. 66, 977 (1987).
D. Strum and E. I. Eger II, Anesth. Analg. 66, 654 (1987).
J. Russell, A. Szur, and R. C. Terrell, U.S. Patent 3, 897, 502 (to Airco) [CA 83, 178306 (1975)].
R. C. Terrell, U.S. Patent 4, 762, 856 (to BOC) [CA 109, 189832 (1988)].
K. Toshikazu, U.K. Patent Appl. GB 2, 219, 292 (to Central Glass, Japan) [CA 112, 234804 (1990)].
M. L. Robin and D. Halpern, Eur. Patent Appl. EP 341, 004 (to BOC) [CA 112, 178046 (1990)].
D. Halpern and M. L. Robin, U.S. Patent 4, 855, 511 (to BOC), [CA 112, 54963 (1990)].
G. Siegemund, Chem. Ber. 106, 2960 (1973).
H. Muffler and R. Franz, Ger. Offen. 28 23 969 (to Hoechst) [CA 92, 197322 (1980)].
M. L. Robin and D. Halpern, Eur. Patent Appl. EP 352, 034 (to BOC) [CA 113, 39937 (1990)].
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Halpern, D.F. (1994). Fluorinated Inhalation Anesthetics. In: Banks, R.E., Smart, B.E., Tatlow, J.C. (eds) Organofluorine Chemistry. Topics in Applied Chemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1202-2_26
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1202-2_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1204-6
Online ISBN: 978-1-4899-1202-2
eBook Packages: Springer Book Archive